The DOI matches its Crossref record; 687 of the 687 references it cites were found in a registry or an index.
Pharmacology of Heparin and Related Drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Ganesh, V. K., Smith, S. A., Kotwal, G. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400744101 · Cited by 56
RetractedThe Solution Structure of Heparan Sulfate Differs from That of Heparin
Khan, S., Rodríguez, E., Patel, R., Gor, J., Mulloy, B., & Perkins, S. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226027 · Cited by 53
Self-citationRetractedKearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F., Brady, A. J. B., Ferreira, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn310 · Cited by 2,826
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Lawrence, M. B., & Springer, T. A. (1991) · Cell · doi:10.1016/0092-8674(91)90393-d · Cited by 2,129
Prevention of VTE in Orthopedic Surgery Patients
Falck-Ytter, Y., Francis, C. W., Johanson, N. A., Curley, C., Dahl, O. E., Schulman, S., Ortel, T. L., Pauker, S. G., & Colwell, C. W. (2012) · Chest · doi:10.1378/chest.11-2404 · Cited by 1,930
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Endorsed by the European Society of Gynecology (ESG), T. A. F. E. P. C. (., Authors/Task Force Members, Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J.-M., Gibbs, J. S. R., Gohlke-Baerwolf, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr218 · Cited by 1,924
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4
Zimmerman, L. B., De Jesús-Escobar, J. M., & Harland, R. M. (1996) · Cell · doi:10.1016/s0092-8674(00)80133-6 · Cited by 1,633
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM
Barritt, D. W., & Jordan, S. C. (1960) · The Lancet · doi:10.1016/s0140-6736(60)92299-6 · Cited by 1,354
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Konstantinides, S., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M., Humbert, M., Kucher, N., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0211 · Cited by 1,349
Molecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.21 · Cited by 1,301
Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., & Mohammadi, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00073-3 · Cited by 1,199
New Fundamentals in Hemostasis
Versteeg, H. H., Heemskerk, J. W. M., Levi, M., & Reitsma, P. H. (2013) · Physiological Reviews · doi:10.1152/physrev.00016.2011 · Cited by 1,126
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Role of tau protein in both physiological and pathological conditions
AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., & Raschke, R. (2004) · Chest · doi:10.1378/chest.126.3_suppl.188s · Cited by 971
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
WuDunn, D., & Spear, P. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.52-58.1989 · Cited by 919
Mast cell secretory granules: armed for battle
Wernersson, S., & Pejler, G. (2014) · Nature Reviews Immunology · doi:10.1038/nri3690 · Cited by 906
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa035451 · Cited by 887
A 14-year study of heparin-induced thrombocytopenia
Warkentin, T. E., & Kelton, J. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00258-6 · Cited by 886
Martel, N., Lee, J., & Wells, P. S. (2005) · Blood · doi:10.1182/blood-2005-04-1546 · Cited by 875
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M. O., Brodsky, F. M., Marasa, J., Bagchi, D. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301440110 · Cited by 859
Schmidt, E. P., Yang, Y., Janssen, W. J., Gandjeva, A., Perez, M. J., Barthel, L., Zemans, R. L., Bowman, J. C., Koyanagi, D. E., Yunt, Z. X., et al. (2012) · Nature Medicine · doi:10.1038/nm.2843 · Cited by 848
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Warkentin, T. E., Greinacher, A., Koster, A., & Lincoff, A. M. (2008) · Chest · doi:10.1378/chest.08-0677 · Cited by 816
Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis
Roberts, R., Gallagher, J., Spooncer, E., Alien, T. D., Bloomfield, F., & Dexter, T. M. (1988) · Nature · doi:10.1038/332376a0 · Cited by 807
Demystifying Heparan Sulfate–Protein Interactions
Xu, D., & Esko, J. D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035314 · Cited by 805
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Heparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Greer, I. A., & Nelson-Piercy, C. (2005) · Blood · doi:10.1182/blood-2005-02-0626 · Cited by 797 · cited 2×
“…or prophylaxis in pregnancy (Hirsh et al., 2001; James, 2007; Regitz-Zagrosek et al., 2011; Bates et al., 2012; Konstantinides et al., 2014) and have been shown to be safe and effective in this population (Lepercq et al., 2001; Rodie et al., 2002; Greer and Nelson-Piercy, 2005; Kher et al., 2007).”
BackgroundSuppression by heparin of smooth muscle cell proliferation in injured arteries
CLOWES, A. W., & KARNOWSKY, M. J. (1977) · Nature · doi:10.1038/265625a0 · Cited by 790
Synthesis and medical applications of oligosaccharides
Seeberger, P. H., & Werz, D. B. (2007) · Nature · doi:10.1038/nature05819 · Cited by 755
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
Schulman, S., Beyth, R. J., Kearon, C., & Levine, M. N. (2008) · Chest · doi:10.1378/chest.08-0674 · Cited by 740
Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.
Miller, M. D., & Krangel, M. S. (1992) · PubMed · Cited by 731
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., & Blundell, T. L. (2000) · Nature · doi:10.1038/35039551 · Cited by 704
Self-citationOsman, I. (2003) · Molecular Human Reproduction · doi:10.1093/molehr/gag001 · Cited by 704
Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J., Sparling, T., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 700
The anticoagulant activation of antithrombin by heparin
Jin, L., Abrahams, J. P., Skinner, R., Petitou, M., Pike, R. N., & Carrell, R. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14683 · Cited by 685
Neutrophils scan for activated platelets to initiate inflammation
Sreeramkumar, V., Adrover, J. M., Ballesteros, I., Cuartero, M. I., Rossaint, J., Bilbao, I., Nácher, M., Pitaval, C., Radovanovic, I., Fukui, Y., et al. (2014) · Science · doi:10.1126/science.1256478 · Cited by 650
Choay, J., Petitou, M., Lormeau, J. C., Sinaÿ, P., Casu, B., & Gatti, G. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90550-8 · Cited by 647
Taylor, K. R., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4682rev · Cited by 639
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
Guerrini, M., Beccati, D., Shriver, Z., Naggi, A., Viswanathan, K., Bisio, A., Capila, I., Lansing, J. C., Guglieri, S., Fraser, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1407 · Cited by 628
Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
Kishimoto, T. K., Viswanathan, K., Ganguly, T., Elankumaran, S., Smith, S., Pelzer, K., Lansing, J. C., Sriranganathan, N., Zhao, G., Galcheva-Gargova, Z., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803200 · Cited by 621
Haemostasis in Normal Pregnancy
Stirling, Y., Woolf, L., North, W. R. S., Seghatchian, M. J., & Meade, T. W. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661167 · Cited by 600
Zhou, H., Romano, P., & White, R. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-03-0152 · Cited by 598
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
White, R. H., Romano, P. S., Zhou, H., Rodrigo, J., & Bargar, W. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1525 · Cited by 588
Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583
Hirsh, J., Dalen, J. E., Deykin, D., & Toller, L. (1992) · Chest · doi:10.1378/chest.102.4_supplement.337s · Cited by 558
Kinnaird, T. D., Stabile, E., Mintz, G. S., Lee, C. W., Canos, D. A., Gevorkian, N., Pinnow, E. E., Kent, K. M., Pichard, A. D., Satler, L. F., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00972-x · Cited by 542
Structural basis of BMP signalling inhibition by the cystine knot protein Noggin
Groppe, J., Greenwald, J., Wiater, E., Rodriguez-Leon, J., Economides, A. N., Kwiatkowski, W., Affolter, M., Vale, W. W., Belmonte, J. C. I., & Choe, S. (2002) · Nature · doi:10.1038/nature01245 · Cited by 533
THE THROMBOPLASTIC ACTION OF CEPHALIN
McLean, J. (1916) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1916.41.2.250 · Cited by 530
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Ilan, N., Elkin, M., & Vlodavsky, I. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.06.004 · Cited by 524
Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
Nelson, R., Cecconi, O., Roberts, W., Aruffo, A., Linhardt, R., & Bevilacqua, M. (1993) · Blood · doi:10.1182/blood.v82.11.3253.3253 · Cited by 516
Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate.
Turnbull, J. E., Fernig, D. G., Ke, Y., Wilkinson, M. C., & Gallagher, J. T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50023-0 · Cited by 514
(1998) · Elsevier eBooks · doi:10.1016/b978-0-12-186060-8.x5000-1 · Cited by 508
REGULATION OF PROTEIN FUNCTION BY GLYCOSAMINOGLYCANS—AS EXEMPLIFIED BY CHEMOKINES
Handel, T. M., Johnson, Z., Crown, S. E., Lau, E. K., Sweeney, M., & Proudfoot, A. E. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161747 · Cited by 508
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.
Lindahl, U., Bäckström, G., Thunberg, L., & Leder, I. G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6551 · Cited by 498
Mechanism of the anticoagulant action of heparin
Bj�rk, I., & Lindahl, U. (1982) · Molecular and Cellular Biochemistry · doi:10.1007/bf00421226 · Cited by 494
The separation of active and inactive forms of heparin
Lam, L. H., Silbert, J. E., & Rosenberg, R. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90558-1 · Cited by 492
Broze, G. J., Warren, L., Novotny, W., Higuchi, D., Girard, J., & Miletich, J. (1988) · Blood · doi:10.1182/blood.v71.2.335.335 · Cited by 485
Thrombosis: a major contributor to the global disease burden
Raskob, G. E., Angchaisuksiri, P., Blanco, A. N., Buller, H., Gallus, A., Hunt, B. J., Hylek, E. M., Kakkar, A., Konstantinides, S. V., McCumber, M., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12698 · Cited by 484
Heparin-induced thrombocytopenia: laboratory studies
Kelton, J., Sheridan, D., Santos, A., Smith, J., Steeves, K., Smith, C., Brown, C., & Murphy, W. (1988) · Blood · doi:10.1182/blood.v72.3.925.925 · Cited by 483
Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-Gullberg, M., Eriksson, I., Ledin, J., Hellman, L., & Kjellén, L. (1999) · Nature · doi:10.1038/23488 · Cited by 481
Structure and function of heparan sulphate proteoglycans
Gallagher, J. T., Lyon, M., & Steward, W. P. (1986) · Biochemical Journal · doi:10.1042/bj2360313 · Cited by 480
Heparan sulfate: decoding a dynamic multifunctional cell regulator
Turnbull, J., Powell, A., & Guimond, S. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01897-3 · Cited by 474
Heparanase: a key enzyme involved in cell invasion
Parish, C. R., Freeman, C., & Hulett, M. D. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00017-8 · Cited by 466
Dalteparin versus Unfractionated Heparin in Critically Ill Patients
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014475 · Cited by 459
Andersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Sims, G. E. C. (1976) · Thrombosis Research · doi:10.1016/0049-3848(76)90105-5 · Cited by 457
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Bullock, S. L., Fletcher, J. M., Beddington, R. S. P., & Wilson, V. A. (1998) · Genes & Development · doi:10.1101/gad.12.12.1894 · Cited by 455
Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana, M., Casu, B., & Lindahl, U. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80470-0 · Cited by 454
Interactions between heparan sulfate and proteins: the concept of specificity
Kreuger, J., Spillmann, D., Li, J.-P., & Lindahl, U. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604035 · Cited by 449
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
Lim, W., Dentali, F., Eikelboom, J. W., & Crowther, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-9-200605020-00011 · Cited by 443
Heparin is essential for the storage of specific granule proteases in mast cells
Humphries, D. E., Wong, G. W., Friend, D. S., Gurish, M. F., Qiu, W.-T., Huang, C., Sharpe, A. H., & Stevens, R. L. (1999) · Nature · doi:10.1038/23481 · Cited by 428
Höök, M., Björk, I., Hopwood, J., & Lindahl, U. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80592-3 · Cited by 423
Ghosh, T. K., Eis, P. S., Mullaney, J. M., Ebert, C., & Gill, D. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37923-7 · Cited by 419
Heparin Binding Nanostructures to Promote Growth of Blood Vessels
Rajangam, K., Behanna, H. A., Hui, M. J., Han, X., Hulvat, J. F., Lomasney, J. W., & Stupp, S. I. (2006) · Nano Letters · doi:10.1021/nl0613555 · Cited by 412
Toxicity of Eosinophil Cationic Proteins for Guinea Pig Tracheal Epithelium In Vitro
Motojima, S., Frigas, E., Loegering, D. A., & Gleich, G. J. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.3.801 · Cited by 412
N.m.r. and molecular-modelling studies of the solution conformation of heparin
Mulloy, B., Forster, M. J., Jones, C., & Davies, D. B. (1993) · Biochemical Journal · doi:10.1042/bj2930849 · Cited by 410
Self-citationVenous thromboembolism and prognosis in cancer
Khorana, A. A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.12.023 · Cited by 410
Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
Xu, Y., Masuko, S., Takieddin, M., Xu, H., Liu, R., Jing, J., Mousa, S. A., Linhardt, R. J., & Liu, J. (2011) · Science · doi:10.1126/science.1207478 · Cited by 407
Li, W., Johnson, D. J. D., Esmon, C. T., & Huntington, J. A. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb811 · Cited by 405
Koenig, A., Norgard-Sumnicht, K., Linhardt, R., & Varki, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1509 · Cited by 403
Guyton, J. R., Rosenberg, R. D., Clowes, A. W., & Karnovsky, M. J. (1980) · Circulation Research · doi:10.1161/01.res.46.5.625 · Cited by 394
Hirsh, J., Raschke, C. R., Warkentin, T. E., Dalen, J. E., Deykin, D., & Poller, L. (1995) · Chest · doi:10.1378/chest.108.4_supplement.258s · Cited by 394
Therapies from Fucoidan; Multifunctional Marine Polymers
Fitton, J. H. (2011) · Marine Drugs · doi:10.3390/md9101731 · Cited by 392
Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon
Haustein, K.-O. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-996417 · Cited by 387
Quinlan, D. J., McQuillan, A., & Eikelboom, J. W. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00008 · Cited by 386
Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)
Sandset, P. M., Abildgaard, U., & Larsen, M. L. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90340-4 · Cited by 386
The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics
van Boeckel, C. A. A., & Petitou, M. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199316713 · Cited by 382
Oligosaccharide Analysis by Mass Spectrometry: A Review of Recent Developments
Kailemia, M. J., Ruhaak, L. R., Lebrilla, C. B., & Amster, I. J. (2014) · Analytical Chemistry · doi:10.1021/ac403969n · Cited by 377
Structure and biological interactions of heparin and heparan sulfate
Casu, B., & Lindahl, U. (2001) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(01)57017-1 · Cited by 375
Structure of a heparin-linked biologically active dimer of fibroblast growth factor
DiGabriele, A. D., Lax, I., Chen, D. I., Svahn, C. M., Jaye, M., Schlessinger, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31741 · Cited by 353
Monréal, M., Lafoz, E., Olivé, A., et al. (1994) · PubMed · Cited by 352
Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications
Liang, Y., & Kiick, K. L. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.07.031 · Cited by 349
Shaping Morphogen Gradients by Proteoglycans
Yan, D., & Lin, X. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002493 · Cited by 348
Cohlberg, J. A., Li, J., Uversky, V. N., & Fink, A. L. (2002) · Biochemistry · doi:10.1021/bi011711s · Cited by 340
Serpin structure, function and dysfunction
HUNTINGTON, J. A. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04360.x · Cited by 330
Synthesis of thrombin-inhibiting heparin mimetics without side effects
Petitou, M., Hérault, J.-P., Bernat, A., Driguez, P.-A., Duchaussoy, P., Lormeau, J.-C., & Herbert, J.-M. (1999) · Nature · doi:10.1038/18877 · Cited by 326
Coupling of glycosaminoglycans to agarose beads (Sepharose 4B)
Iverius, P.-H. (1971) · Biochemical Journal · doi:10.1042/bj1240677 · Cited by 316
DEBOURDEAU, P., FARGE, D., BECKERS, M., BAGLIN, C., BAUERSACHS, R. M., BRENNER, B., BRILHANTE, D., FALANGA, A., GEROTZAFIAS, G. T., HAIM, N., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12071 · Cited by 316
Conformation and dynamics of heparin and heparan sulfate
Mulloy, B., & Forster, M. J. (2000) · Glycobiology · doi:10.1093/glycob/10.11.1147 · Cited by 315
Self-citationUnexpected High Prevalence of Silent Pulmonary Embolism in Patients with Deep Venous Thrombosis
Huisman, M. V., Büller, H. R., ten Cate, J. W., van Royen, E. A., Vreeken, J., Kersten, M.-J., & Bakx, R. (1989) · Chest · doi:10.1378/chest.95.3.498 · Cited by 311
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Leclerc, J., Powers, P. J., Jay, R. M., & Neemeh, J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-7-545 · Cited by 308
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex
Fry, E. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.543 · Cited by 308
BMP signalling: agony and antagony in the family
Brazil, D. P., Church, R. H., Surae, S., Godson, C., & Martin, F. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.004 · Cited by 306
Heparanases and tumor metastasis
Nakajima, M., Irimura, T., & Nicolson, G. L. (1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240360207 · Cited by 305
Vlodavsky, I., Eldor, A., Haimovitz‐Friedman, A., Matzner, Y., Ishai-Michaeli, R., Lider, O., Naparstek, Y., Cohen, I. R., & FUKS, Z. Y. (1992) · PubMed · Cited by 302
Human β-tryptase is a ring-like tetramer with active sites facing a central pore
Pereira, P. J. B., Bergner, A., Macedo-Ribeiro, S., Huber, R., Matschiner, G., Fritz, H., Sommerhoff, C. P., & Bode, W. (1998) · Nature · doi:10.1038/32703 · Cited by 301
Heparan Sulfate Biosynthesis: Regulation and Variability
Kreuger, J., & Kjellén, L. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412464972 · Cited by 301
Monreal, M., Lafoz, E., Olive, A., del Rio, L., & Vedia, C. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642376 · Cited by 299
Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
Maimone, M. M., & Tollefsen, D. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44747-8 · Cited by 297
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
Smorenburg, S. M., & Van Noorden, C. J. F. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01481-9 · Cited by 294
Lobb, R. R., & Fett, J. W. (1984) · Biochemistry · doi:10.1021/bi00321a001 · Cited by 293
Pulmonary Embolism: What have We Learned Since Virchow?
Dalen, J. E. (2002) · Chest · doi:10.1378/chest.122.4.1440 · Cited by 293
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry
Akhtar, J., & Shukla, D. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07402.x · Cited by 292
Domain Structure of Heparan Sulfates from Bovine Organs
Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K., & Lindahl, U. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17804 · Cited by 284
Griffith, G. C. (1965) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1965.03090020005001 · Cited by 284
Heparin-Induced Thrombocytopenia Associated with Fondaparinux
(2007) · New England Journal of Medicine · doi:10.1056/nejmc070346 · Cited by 283
Outbreak of Adverse Reactions Associated with Contaminated Heparin
Blossom, D. B., Kallen, A. J., Patel, P. R., Elward, A., Robinson, L., Gao, G., Langer, R., Perkins, K. M., Jaeger, J. L., Kurkjian, K. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806450 · Cited by 282
Correlation between structure and function of heparin
Rosenberg, R. D., & Lam, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1218 · Cited by 281
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
Kearon, C., & Akl, E. A. (2014) · Blood · doi:10.1182/blood-2013-12-512681 · Cited by 279
Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).
Diamond, M. S., Alon, R., Parkos, C. A., Quinn, M. T., & Springer, T. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.6.1473 · Cited by 279
Structural basis for sialic acid–mediated self-recognition by complement factor H
Blaum, B. S., Hannan, J. P., Herbert, A. P., Kavanagh, D., Uhrín, D., & Stehle, T. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1696 · Cited by 278
Heparins--anionic polyelectrolyte drugs.
Jaques, L. B. (1979) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06829-2 · Cited by 278
Pettilä, V., Leinonen, P., Markkola, A., Hiilesmaa, V., & Kaaja, R. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612970 · Cited by 275
Chapter 3 Interactions Between Heparan Sulfate and Proteins—Design and Functional Implications
(2009) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(09)76003-4 · Cited by 274
Role of heparan sulfate in fibroblast growth factor signalling: a structural view
Pellegrini, L. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00258-x · Cited by 274
Defining the Interleukin-8-binding Domain of Heparan Sulfate
Spillmann, D., Witt, D., & Lindahl, U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15487 · Cited by 273
Modular Synthesis of Heparan Sulfate Oligosaccharides for Structure−Activity Relationship Studies
Arungundram, S., Al-Mafraji, K., Asong, J., Leach, F. E., Amster, I. J., Venot, A., Turnbull, J. E., & Boons, G.-J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907358k · Cited by 272
Lepercq, J., Conard, J., Borel‐Derlon, A., Darmon, J., Boudignat, O., Francoual, C., Priollet, P., Cohen, C., Yvelin, N., Schved, J., et al. (2001) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2003.00272.x · Cited by 271
Examination of the substrate specificity of heparin and heparan sulfate lyases
Linhardt, R. J., Turnbull, J. E., Wang, H. M., Loganathan, D., & Gallagher, J. T. (1990) · Biochemistry · doi:10.1021/bi00462a026 · Cited by 268
Neuronal cell–cell adhesion depends on interactions of N-CAM with heparin-like molecules
Cole, G. J., Loewy, A., & Glaser, L. (1986) · Nature · doi:10.1038/320445a0 · Cited by 265
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Di Nisio, M., Porreca, E., Ferrante, N., Otten, H.-M., Cuccurullo, F., & Rutjes, A. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008500.pub2 · Cited by 264
Guidelines on the use and monitoring of heparin
Baglin, T., Barrowcliffe, T. W., Cohen, A., Greaves, M., & the British Committee for Standards in Haematology (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05953.x · Cited by 262
Gomez-Outes, A., Terleira-Fernandez, A. I., Suarez-Gea, M. L., & Vargas-Castrillon, E. (2012) · BMJ · doi:10.1136/bmj.e3675 · Cited by 261
Structural diversity of heparan sulfate binding domains in chemokines
Lortat-Jacob, H., Grosdidier, A., & Imberty, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032497699 · Cited by 259
Lyon, M., Rushton, G., & Gallagher, J. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.18000 · Cited by 258
Fedarko, N. S., & Conrad, H. E. (1986) · The Journal of cell biology · doi:10.1083/jcb.102.2.587 · Cited by 257
Powell, A. K. (2004) · Glycobiology · doi:10.1093/glycob/cwh051 · Cited by 257
Multiple Isoforms of Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase
Shworak, N. W., Liu, J., Petros, L. M., Zhang, L., Kobayashi, M., Copeland, N. G., Jenkins, N. A., & Rosenberg, R. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5170 · Cited by 252
Heparin in Inflammation: Potential Therapeutic Applications beyond Anticoagulation
Tyrrell, D. J., Horne, A. P., Holme, K. R., Preuss, J. M. H., & Page, C. P. (1999) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60471-8 · Cited by 245
Self-citationHeparanase Gene Silencing, Tumor Invasiveness, Angiogenesis, and Metastasis
Edovitsky, E., Elkin, M., Zcharia, E., Peretz, T., & Vlodavsky, I. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh230 · Cited by 242
Petitou, M. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00078-6 · Cited by 241
Conformer populations of l-iduronic acid residues in glycosaminoglycan sequences
Ferro, D. R., Provasoli, A., Ragazzi, M., Casu, B., Torri, G., Bossennec, V., Perly, B., Sinaÿ, P., Petitou, M., & Choay, J. (1990) · Carbohydrate Research · doi:10.1016/0008-6215(90)84164-p · Cited by 241
Heparan sulfate 3-O-sulfation: A rare modification in search of a function
Thacker, B. E., Xu, D., Lawrence, R., & Esko, J. D. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.12.001 · Cited by 234
Characterization of the Structural Features and Interactions of Sclerostin
Veverka, V., Henry, A. J., Slocombe, P. M., Ventom, A., Mulloy, B., Muskett, F. W., Muzylak, M., Greenslade, K., Moore, A., Zhang, L., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807994200 · Cited by 233
Self-citationEnhanced thrombin generation in normal and hypertensive pregnancy
de Boer, K., ten Cate, J. W., Sturk, A., Borm, J. J. J., & Treffers, P. E. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90096-3 · Cited by 231
Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production
Ledin, J., Staatz, W., Li, J.-P., Götte, M., Selleck, S., Kjellén, L., & Spillmann, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405382200 · Cited by 230
Naggi, A., Casu, B., Perez, M., Torri, G., Cassinelli, G., Penco, S., Pisano, C., Giannini, G., Ishai-Michaeli, R., & Vlodavsky, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414217200 · Cited by 229
Heparin and Heparan Sulfate: Analyzing Structure and Microheterogeneity
Shriver, Z., Capila, I., Venkataraman, G., & Sasisekharan, R. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-23056-1_8 · Cited by 229
Silvain, J., Beygui, F., Barthelemy, O., Pollack, C., Cohen, M., Zeymer, U., Huber, K., Goldstein, P., Cayla, G., Collet, J.-P., et al. (2012) · BMJ · doi:10.1136/bmj.e553 · Cited by 225
Platelets are essential for leukocyte recruitment in allergic inflammation
Pitchford, S. C., Yano, H., Lever, R., Riffo-Vasquez, Y., Ciferri, S., Rose, M. J., Giannini, S., Momi, S., Spina, D., O'Connor, B., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1514 · Cited by 221
Self-citationStevenson, J. L., Choi, S. H., & Varki, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1131 · Cited by 220
McCaffrey, T. A., Falcone, D. J., Brayton, C. F., Agarwal, L. A., Welt, F. G., & Weksler, B. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.441 · Cited by 219
Structure and Biology of Tissue Factor Pathway Inhibitor
Birktoft, J., Steer, S., Bajaj, S. P., & Bajaj, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616518 · Cited by 219
Preventing Bronchoconstriction in Exercise-Induced Asthma with Inhaled Heparin
Ahmed, T., Garrigo, J., & Danta, I. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307083290204 · Cited by 218
Rider, C. C., & Mulloy, B. (2010) · Biochemical Journal · doi:10.1042/bj20100305 · Cited by 215
Self-citationHeparan Sulfate Proteoglycans Retain Noggin at the Cell Surface
Paine-Saunders, S., Viviano, B. L., Economides, A. N., & Saunders, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109151200 · Cited by 213
Kuderer, N. M., Khorana, A. A., Lyman, G. H., & Francis, C. W. (2007) · Cancer · doi:10.1002/cncr.22892 · Cited by 212
Savi, P., Chong, B. H., Greinacher, A., Gruel, Y., Kelton, J. G., Warkentin, T. E., Eichler, P., Meuleman, D., Petitou, M., Herault, J.-P., et al. (2005) · Blood · doi:10.1182/blood-2004-05-2010 · Cited by 212
Mechanistic View of Risk Factors for Venous Thromboembolism
Reitsma, P. H., Versteeg, H. H., & Middeldorp, S. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.242818 · Cited by 211
Chemokines as mediators of angiogenesis
Mehrad, B., Keane, M., & Strieter, R. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0040 · Cited by 211
Zee, A. A., van Lieshout, K., van der Heide, M., Janssen, L., & Janzing, H. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006681.pub4 · Cited by 210
Cancer-Associated Thrombosis: An Overview
Elyamany, G., Alzahrani, A. M., & Bukhary, E. (2014) · Clinical Medicine Insights: Oncology · doi:10.4137/cmo.s18991 · Cited by 209
Characterization of the Stromal Cell-derived Factor-1α-Heparin Complex
Sadir, R., Baleux, F., Grosdidier, A., Imberty, A., & Lortat-Jacob, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008110200 · Cited by 208
Heparin, heparan sulfate and heparanase in inflammatory reactions
Vlodavsky, I., & Li, J.-P. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0091 · Cited by 208
Structural view of glycosaminoglycan–protein interactions
Imberty, A., Lortat-Jacob, H., & Pérez, S. (2007) · Carbohydrate Research · doi:10.1016/j.carres.2006.12.019 · Cited by 207
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
Hettiarachchi, R., Smorenburg, S., Ginsberg, J., Levine, M., Prins, M., & Büller, H. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615937 · Cited by 206
Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1
Lau, E. K., Paavola, C. D., Johnson, Z., Gaudry, J.-P., Geretti, E., Borlat, F., Kungl, A. J., Proudfoot, A. E., & Handel, T. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311224200 · Cited by 204
Heparin-induced aldosterone suppression and hyperkalemia
Oster, J. R., Singer, I., & Fishman, L. M. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80017-5 · Cited by 204
Mechanisms of heparin induced anti-cancer activity in experimental cancer models
Niers, T. M. H., Klerk, C. P. W., DiNisio, M., Van Noorden, C. J. F., Büller, H. R., Reitsma, P. H., & Richel, D. J. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.007 · Cited by 202
Pouplard, C., Iochmann, S., Renard, B., Herault, O., Colombat, P., Amiral, J., & Gruel, Y. (2001) · Blood · doi:10.1182/blood.v97.10.3300 · Cited by 200
Baglin, T. P., Carrell, R. W., Church, F. C., Esmon, C. T., & Huntington, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162232399 · Cited by 199
Serglycin – Structure and biology
Kolset, S. O., & Tveit, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7455-6 · Cited by 199
Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate
Stringer, S. E., & Gallagher, J. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20508 · Cited by 198
GMP-140 binding to neutrophils is inhibited by sulfated glycans.
Skinner, M. P., Lucas, C. M., Burns, G. F., Chesterman, C. N., & Berndt, M. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67603-9 · Cited by 197
Agnelli, G., Buller, H. R., Cohen, A., Gallus, A. S., Lee, T. C., Pak, R., Raskob, G. E., Weitz, J. I., & Yamabe, T. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13153 · Cited by 197
Viviano, B. L., Paine-Saunders, S., Gasiunas, N., Gallagher, J., & Saunders, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310691200 · Cited by 196
Noti, C., de Paz, J. L., Polito, L., & Seeberger, P. H. (2006) · Chemistry – A European Journal · doi:10.1002/chem.200601103 · Cited by 196
Heparin sensing and binding – taking supramolecular chemistry towards clinical applications
Bromfield, S. M., Wilde, E., & Smith, D. K. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60278h · Cited by 194
Cloning and Expression Profiling of Hpa2, a Novel Mammalian Heparanase Family Member
McKenzie, E., Tyson, K., Stamps, A., Smith, P., Turner, P., Barry, R., Hircock, M., Patel, S., Barry, E., Stubberfield, C., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3586 · Cited by 193
Lawrence, R., Olson, S. K., Steele, R. E., Wang, L., Warrior, R., Cummings, R. D., & Esko, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804288200 · Cited by 193
Paradoxical response to heparin in 10 patients with ulcerative colitis.
Gaffney, P. R., Doyle, C. T., Gaffney, A., Hogan, J., Hayes, D. P., & Annis, P. (1995) · PubMed · Cited by 189
Highly Sulfated Dermatan Sulfates from Ascidians
Pavão, M. S. G., Aiello, K. R. M., Werneck, C. C., Silva, L. C. F., Valente, A.-P., Mulloy, B., Colwell, N. S., Tollefsen, D. M., & Mourão, P. A. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27848 · Cited by 189
Self-citationForestier, F., Daffos, F., & Capella-Pavlovsky, M. (1984) · Thrombosis Research · doi:10.1016/0049-3848(84)90260-3 · Cited by 189
Pathophysiology of heparan sulphate: many diseases, few drugs
Lindahl, U., & Kjellén, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12061 · Cited by 189
Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion
Chappell, D., Jacob, M., Hofmann-Kiefer, K., Rehm, M., Welsch, U., Conzen, P., & Becker, B. F. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp097 · Cited by 188
Selectin Blocking Activity of a Fucosylated Chondroitin Sulfate Glycosaminoglycan from Sea Cucumber
Borsig, L., Wang, L., Cavalcante, M. C. M., Cardilo-Reis, L., Ferreira, P. L., Mourąo, P. A. S., Esko, J. D., & Pavąo, M. S. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610560200 · Cited by 187
Structural basis for complement factor H linked age-related macular degeneration
Prosser, B. E., Johnson, S., Roversi, P., Herbert, A. P., Blaum, B. S., Tyrrell, J., Jowitt, T. A., Clark, S. J., Tarelli, E., Uhrín, D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071069 · Cited by 184 · cited 2×
“It is known that mutations at or near the heparin binding site in CFH CCP 6–8 can predispose to agerelated macular degeneration (Prosser et al., 2007), and that mutations at or near the CCP 19–20 site are associated with atypical hemolytic uremic syndrome (Józsi et al., 2006).”
BackgroundOlson, S. T., Richard, B., Izaguirre, G., et al. (2010) · Biochimie · doi:10.1016/j.biochi.2010.05.011 · Cited by 183
Cited by
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
Gritsch, L., Conoscenti, G., La Carrubba, V., Nooeaid, P., & Boccaccini, A. R. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2018.09.038 · Cited by 51
Metadata
- Authors
- Mulloy, B., Hogwood, J., Gray, E., Lever, R., & Page, C. P.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 68
- Issue
- 1
- Pages
- 76-141
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2212792660
- Cited by
- 341
- References
- 687
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.